Agenda
15:35 (BST)
Charles Mullighan
What is immunotherapy, and how does it treat ALL?
- How different immunotherapies work, and why we use them for ALL
- Traditional treatment overview, and how immunotherapy fits into the treatment landscape
- Key differences between immunotherapy and chemotherapy
15:45 (BST)
Wendy Stock
What immunotherapies are available for the treatment of ALL?
- Overview of approved and investigational immunotherapies for the treatment of ALL
- Which patients are eligible for immunotherapies, and when they are given in the treatment journey
15:55 (BST)
Jessica Olson, Jaymz Goodman, Charles Mullighan, Wendy Stock
Patient voice: Lived experience with immunotherapies, and insights for better patient care
- Patient presentation of their experience with immunotherapies in ALL, including patient journey, side effects, and what HCPs need to know
- Panel discussion featuring patient and HCP representation to discuss how to improve the patient experience with novel therapies, including immunotherapies
16:25 (BST)
Jaymz Goodman
Closing remarks
- Key takeaways for patients
- Links to credible resources
- Q&A and post-webinar evaluation
Learning objectives
After attending this webinar, learners will be able to:
- Describe how immunotherapies work and why they are used in ALL.
- Identify which patients are eligible for immunotherapies in ALL.
- Recall the strategies to manage the adverse effects associated with immunotherapies in ALL.
- Recall the supportive care strategies for immunotherapies in ALL.
- Recall the strategies to increase effective patient–HCP communication.
Know ALL uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy